MF Scanlon

DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASES

D. Kiddy, P. S. Sharp, Davinia White et al. · Clinical Endocrinology · 1990 · 365 citations

Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

John S. Bevan, Stephen L. Atkin, A. B. Atkinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 277 citations · Full text

Treatment of macroprolactinoma with cabergoline: a study of 85 patients

Carlo Ferrari, Roger Abs, J. S. Bevan et al. · Clinical Endocrinology · 1997 · 167 citations

The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency

LM Evans, RA Anderson, G Ellis et al. · European Journal of Endocrinology · 2000 · 108 citations

Dose‐dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study

Jonathan Webster, G. Piscitelli, Anna Polli et al. · Clinical Endocrinology · 1992 · 71 citations